Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE:002294)

Market Cap	33.24B
Revenue (ttm)	3.91B
Net Income (ttm)	610.61M
Shares Out	1.11B
EPS (ttm)	0.55
PE Ratio	54.25
Forward PE	49.70
Dividend	0.50 (1.68%)
Ex-Dividend Date	n/a

Volume	19,656,519
Average Volume	7,042,294
Open	29.65
Previous Close	28.36
Day's Range	28.48 - 30.18
52-Week Range	25.51 - 38.10
Beta	0.65
RSI	51.14
Earnings Date	Mar 25, 2025

About SHE:002294

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines and medical devices in China. The company offers drugs for various therapeutic fields, such as thrombosis, hypertension and related diseases, osteoporosis, and infections, as well as anti-osteolysis, antiallergic, antiepileptic, and antidepressant medicines. It also provides interventional medical devices for therapy of cardiovascular and cerebrovascular diseases, peripheral blood vessels, structural heart diseases, electrophysiol...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1998
• Employees: 3,517
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002294

Financial Performance

In 2023, SHE:002294's revenue was 3.37 billion, a decrease of -3.35% compared to the previous year's 3.48 billion. Earnings were 580.07 million, a decrease of -8.95%.